neuropathic pain phenotype
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| CACNA2D2 | associated_with | neuropathic pain | — | 1 |
| gabapentin | protective_against | neuropathic pain | — | 1 |
| gabapentin | associated_with | neuropathic pain | — | 1 |
Mentioned in (11)
Papers in which this entity is mentioned.
- Transient Potassium Channels: Therapeutic Targets for Brain Disorders. (2019)
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018)
- An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
- CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. (2016)
- Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats. (2014)
- Gabapentin treatment for alcohol dependence: a randomized clinical trial. (2014)
- Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. (2013)
- Long-lasting neural circuit dysfunction following developmental ethanol exposure. (2013)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
- Adrenomedullin signaling is necessary for murine lymphatic vascular development. (2008)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| neuropathic pain | phenotype | 11 | 17 |